BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29514830)

  • 21. Progenitor Cells and Clinical Outcomes in Patients With Heart Failure.
    Samman Tahhan A; Hammadah M; Sandesara PB; Hayek SS; Kalogeropoulos AP; Alkhoder A; Mohamed Kelli H; Topel M; Ghasemzadeh N; Chivukula K; Ko YA; Aida H; Hesaroieh I; Mahar E; Kim JH; Wilson P; Shaw L; Vaccarino V; Waller EK; Quyyumi AA
    Circ Heart Fail; 2017 Aug; 10(8):. PubMed ID: 28790053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced mobilization of the bone marrow-derived circulating progenitor cells by intracoronary freshly isolated bone marrow cells transplantation in patients with acute myocardial infarction.
    Turan RG; Bozdag-T I; Turan CH; Ortak J; Akin I; Kische S; Schneider H; Rauchhaus M; Rehders TC; Kleinfeldt T; Belu C; Amen S; Hermann T; Yokus S; Brehm M; Steiner S; Chatterjee T; Sahin K; Nienaber CA; Ince H
    J Cell Mol Med; 2012 Apr; 16(4):852-64. PubMed ID: 21707914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic role of soluble ST2 in acute coronary syndrome with diabetes.
    Jha D; Goenka L; Ramamoorthy T; Sharma M; Dhandapani VE; George M
    Eur J Clin Invest; 2018 Sep; 48(9):e12994. PubMed ID: 29992539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The number and function of circulating CD34(+)CD133(+) progenitor cells decreased in stable coronary artery disease but not in acute myocardial infarction.
    Kondo T; Shintani S; Maeda K; Hayashi M; Inden Y; Numaguchi Y; Sugiura K; Morita Y; Kitamura T; Kamiya H; Sone T; Ohno M; Murohara T
    Heart Asia; 2010; 2(1):20-3. PubMed ID: 27325937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Migratory activity of circulating progenitor cells and serum SDF-1α predict adverse events in patients with myocardial infarction.
    Fortunato O; Spinetti G; Specchia C; Cangiano E; Valgimigli M; Madeddu P
    Cardiovasc Res; 2013 Nov; 100(2):192-200. PubMed ID: 23761401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coincidence of moderately elevated N-terminal pro-B-type natriuretic peptide, endothelial progenitor cells deficiency and propensity to exercise-induced myocardial ischemia in stable angina.
    Surdacki A; Marewicz E; Rakowski T; Szumańska M; Szastak G; Pryjma J; Dubiel JS
    Dis Markers; 2010; 28(2):101-14. PubMed ID: 20364046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Factors influencing mobilisation of endothelial progenitor cells and angiogenic cytokines after an extensive acute myocardial infarction].
    Domínguez-Franco A; González FJ; Rodríguez-Losada N; Marchal JA; Cabrera-Bueno F; Carrillo E; Gómez-Doblas JJ; Perán M; Alonso-Briales JH; Jiménez-Navarro MF; Aránega A; De Teresa Galván E;
    Med Clin (Barc); 2012 Apr; 138(10):415-21. PubMed ID: 22197368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Ticagrelor Versus Prasugrel for Inflammation, Vascular Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Requiring Coronary Stenting: A Prospective, Randomized, Crossover Trial.
    Jeong HS; Hong SJ; Cho SA; Kim JH; Cho JY; Lee SH; Joo HJ; Park JH; Yu CW; Lim DS
    JACC Cardiovasc Interv; 2017 Aug; 10(16):1646-1658. PubMed ID: 28838475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating Progenitor Cells Identify Peripheral Arterial Disease in Patients With Coronary Artery Disease.
    Hayek SS; MacNamara J; Tahhan AS; Awad M; Yadalam A; Ko YA; Healy S; Hesaroieh I; Ahmed H; Gray B; Sher SS; Ghasemzadeh N; Patel R; Kim J; Waller EK; Quyyumi AA
    Circ Res; 2016 Aug; 119(4):564-71. PubMed ID: 27267067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function.
    Leone AM; Rutella S; Bonanno G; Abbate A; Rebuzzi AG; Giovannini S; Lombardi M; Galiuto L; Liuzzo G; Andreotti F; Lanza GA; Contemi AM; Leone G; Crea F
    Eur Heart J; 2005 Jun; 26(12):1196-204. PubMed ID: 15734770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating CD34+ progenitor cells and risk of mortality in a population with coronary artery disease.
    Patel RS; Li Q; Ghasemzadeh N; Eapen DJ; Moss LD; Janjua AU; Manocha P; Kassem HA; Veledar E; Samady H; Taylor WR; Zafari AM; Sperling L; Vaccarino V; Waller EK; Quyyumi AA
    Circ Res; 2015 Jan; 116(2):289-297. PubMed ID: 25323857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex Differences in Circulating Progenitor Cells.
    Topel ML; Hayek SS; Ko YA; Sandesara PB; Samman Tahhan A; Hesaroieh I; Mahar E; Martin GS; Waller EK; Quyyumi AA
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28974500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced functional response of CD133+ circulating progenitor cells in patients early after acute myocardial infarction.
    Vöö S; Eggermann J; Dunaeva M; Ramakers-van Oosterhoud C; Waltenberger J
    Eur Heart J; 2008 Jan; 29(2):241-50. PubMed ID: 18156140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating CD34+/133+ progenitor cells in patients with stable angina pectoris undergoing percutaneous coronary intervention.
    Arao K; Yasu T; Ohmura N; Tsukamoto Y; Murata M; Kubo N; Umemoto T; Ikeda N; Ako J; Ishikawa SE; Kawakami M; Momomura S
    Circ J; 2010 Sep; 74(9):1929-35. PubMed ID: 20625217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation between the frequency of CD34⁺ bone marrow derived circulating progenitor cells and the number of diseased coronary arteries in patients with myocardial ischemia and diabetes.
    Bozdag-Turan I; Turan RG; Turan CH; Ludovicy S; Akin I; Kische S; Arsoy NS; Schneider H; Ortak J; Rehders T; Hermann T; Paranskaya L; Kohlschein P; Bastian M; Ulus AT; Sahin K; Ince H; Nienaber CA
    Cardiovasc Diabetol; 2011 Nov; 10():107. PubMed ID: 22118372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-941 as a promising biomarker for acute coronary syndrome.
    Bai R; Yang Q; Xi R; Li L; Shi D; Chen K
    BMC Cardiovasc Disord; 2017 Aug; 17(1):227. PubMed ID: 28830367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increase in circulating bone marrow progenitor cells after myocardial infarction.
    Spevack DM; Cavaleri S; Zolotarev A; Liebes L; Inghirami G; Tunick PA; Kronzon I
    Coron Artery Dis; 2006 May; 17(4):345-9. PubMed ID: 16707957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulating factors of progenitor stem cell kinetics in STEMI patients undergoing primary angioplasty - a pilot study.
    Micheu MM; Oprescu N; Câlmâc L; Scafa-Udrişte A; Dorobanţu M
    Rom J Morphol Embryol; 2014; 55(4):1389-94. PubMed ID: 25611271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced mobilization of CD34(+) progenitor cells expressing cell adhesion molecules in patients with STEMI.
    Brehm M; Ebner P; Picard F; Urbien R; Turan G; Strauer BE
    Clin Res Cardiol; 2009 Aug; 98(8):477-86. PubMed ID: 19479183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association Between Plasma ADAMTS-9 Levels and Severity of Coronary Artery Disease.
    Wei M; Pan H; Guo K
    Angiology; 2021 Apr; 72(4):371-380. PubMed ID: 33307720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.